Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nohla Therapeutics

Nohla Therapeutics?uq=UG6efJS6
2015 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series B LATEST DEAL TYPE
$56M LATEST DEAL AMOUNT
12 INVESTORS
Description

Developer of universal, off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases. The company's lead candidate, is an expanded progenitor cell therapy that provides the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1600 Fairview Avenue East
  • Suite 100
  • Seattle, WA 98102
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nohla Therapeutics’s full profile, request a free trial.

Nohla Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 12-Jul-2018 $56M 00000 Completed Clinical Trials - Phase 2
3. Grant 28-Sep-2017 00.00 000.00 Completed Startup
2. Early Stage VC (Series A) 29-Nov-2016 $43.5M $64.5M 00000 Completed Startup
1. Corporate 24-Dec-2015 $21M $21M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nohla Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view this company’s complete Cap Table, request access »

Nohla Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
AML Biotech Partners Other Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
Fidelity Management & Research Asset Manager Minority 000 0000 000000 0
Premier Partners Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Nohla Therapeutics Executive Team (10)

Name Title Board
Seat
Contact
Info
Kathleen Fanning President, Chief Executive Officer & Board Member
James Johnson Chief Financial Officer
Gary Christianson Chief Operating Officer
Colleen Delaney MD Chief Scientific Officer & Founder
Shelly Heimfeld Ph.D Executive Vice President of Research and Manufacturing

3 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Nohla Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Brian Daniels MD 5AM Ventures Board Member 000 0000
Ian Brown Nohla Therapeutics Board Member 000 0000
Kathleen Fanning Nohla Therapeutics President, Chief Executive Officer & Board Member 000 0000
Lawrence Gozlan Nohla Therapeutics Board Member 000 0000
Michael Sistenich Nohla Therapeutics Non-Executive Board of Directors 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »